nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—CYP3A4—Temozolomide—brain cancer	0.101	0.344	CbGbCtD
Naloxone—CYP3A4—Lomustine—brain cancer	0.0859	0.293	CbGbCtD
Naloxone—CYP2C8—Etoposide—brain cancer	0.0512	0.174	CbGbCtD
Naloxone—ABCB1—Etoposide—brain cancer	0.0346	0.118	CbGbCtD
Naloxone—CREB1—telencephalic ventricle—brain cancer	0.0215	0.0992	CbGeAlD
Naloxone—CYP3A4—Etoposide—brain cancer	0.0207	0.0707	CbGbCtD
Naloxone—CREB1—ganglion—brain cancer	0.0134	0.0617	CbGeAlD
Naloxone—OPRM1—telencephalic ventricle—brain cancer	0.0116	0.0535	CbGeAlD
Naloxone—OPRD1—ganglion—brain cancer	0.0106	0.0488	CbGeAlD
Naloxone—CREB1—hindbrain—brain cancer	0.0102	0.0468	CbGeAlD
Naloxone—OPRM1—ganglion—brain cancer	0.00722	0.0333	CbGeAlD
Naloxone—TLR4—cerebellum—brain cancer	0.00652	0.0301	CbGeAlD
Naloxone—CREB1—brainstem—brain cancer	0.00582	0.0268	CbGeAlD
Naloxone—Grand mal convulsion—Carmustine—brain cancer	0.00543	0.0403	CcSEcCtD
Naloxone—TLR4—brain—brain cancer	0.0053	0.0244	CbGeAlD
Naloxone—CREB1—telencephalon—brain cancer	0.00517	0.0238	CbGeAlD
Naloxone—CREB1—gonad—brain cancer	0.00431	0.0199	CbGeAlD
Naloxone—CREB1—pituitary gland—brain cancer	0.00421	0.0194	CbGeAlD
Naloxone—ESR1—blood vessel—brain cancer	0.00419	0.0193	CbGeAlD
Naloxone—OPRD1—telencephalon—brain cancer	0.00409	0.0188	CbGeAlD
Naloxone—CREB1—medulla oblongata—brain cancer	0.00406	0.0187	CbGeAlD
Naloxone—Encephalopathy—Carmustine—brain cancer	0.00403	0.0299	CcSEcCtD
Naloxone—ESR1—hindbrain—brain cancer	0.004	0.0184	CbGeAlD
Naloxone—Coma—Procarbazine—brain cancer	0.00378	0.028	CcSEcCtD
Naloxone—CREB1—midbrain—brain cancer	0.00371	0.0171	CbGeAlD
Naloxone—CREB1—spinal cord—brain cancer	0.00362	0.0167	CbGeAlD
Naloxone—CREB1—endocrine gland—brain cancer	0.00326	0.015	CbGeAlD
Naloxone—CREB1—head—brain cancer	0.00322	0.0148	CbGeAlD
Naloxone—OPRM1—brainstem—brain cancer	0.00314	0.0145	CbGeAlD
Naloxone—CREB1—central nervous system—brain cancer	0.00294	0.0135	CbGeAlD
Naloxone—CREB1—cerebellum—brain cancer	0.00287	0.0132	CbGeAlD
Naloxone—Pulmonary oedema—Hydroxyurea—brain cancer	0.00285	0.0211	CcSEcCtD
Naloxone—OPRM1—telencephalon—brain cancer	0.00279	0.0128	CbGeAlD
Naloxone—Buprenorphine—CYP2C9—brain cancer	0.00261	0.504	CrCbGaD
Naloxone—Injection site reaction—Carmustine—brain cancer	0.00257	0.0191	CcSEcCtD
Naloxone—Hydromorphone—CYP2C9—brain cancer	0.00257	0.496	CrCbGaD
Naloxone—OPRD1—head—brain cancer	0.00254	0.0117	CbGeAlD
Naloxone—OPRK1—head—brain cancer	0.00244	0.0112	CbGeAlD
Naloxone—SLCO1A2—telencephalon—brain cancer	0.0024	0.0111	CbGeAlD
Naloxone—Coma—Carmustine—brain cancer	0.00236	0.0175	CcSEcCtD
Naloxone—CREB1—brain—brain cancer	0.00233	0.0107	CbGeAlD
Naloxone—OPRD1—central nervous system—brain cancer	0.00232	0.0107	CbGeAlD
Naloxone—ESR1—brainstem—brain cancer	0.00229	0.0106	CbGeAlD
Naloxone—Pain—Carboplatin—brain cancer	0.00227	0.0168	CcSEcCtD
Naloxone—OPRK1—central nervous system—brain cancer	0.00223	0.0103	CbGeAlD
Naloxone—Sweating—Procarbazine—brain cancer	0.00222	0.0164	CcSEcCtD
Naloxone—OPRK1—cerebellum—brain cancer	0.00218	0.01	CbGeAlD
Naloxone—Body temperature increased—Carboplatin—brain cancer	0.0021	0.0156	CcSEcCtD
Naloxone—Hallucination—Procarbazine—brain cancer	0.00207	0.0153	CcSEcCtD
Naloxone—ESR1—telencephalon—brain cancer	0.00203	0.00938	CbGeAlD
Naloxone—OPRM1—midbrain—brain cancer	0.002	0.00922	CbGeAlD
Naloxone—OPRM1—spinal cord—brain cancer	0.00195	0.009	CbGeAlD
Naloxone—Hot flush—Temozolomide—brain cancer	0.00194	0.0144	CcSEcCtD
Naloxone—Flushing—Procarbazine—brain cancer	0.00193	0.0143	CcSEcCtD
Naloxone—Menopausal symptoms—Temozolomide—brain cancer	0.00192	0.0143	CcSEcCtD
Naloxone—SLCO1A2—medulla oblongata—brain cancer	0.00188	0.00869	CbGeAlD
Naloxone—Chills—Procarbazine—brain cancer	0.00186	0.0138	CcSEcCtD
Naloxone—OPRD1—brain—brain cancer	0.00184	0.0085	CbGeAlD
Naloxone—Body temperature increased—Lomustine—brain cancer	0.00184	0.0136	CcSEcCtD
Naloxone—Tension—Procarbazine—brain cancer	0.00177	0.0132	CcSEcCtD
Naloxone—OPRK1—brain—brain cancer	0.00177	0.00814	CbGeAlD
Naloxone—OPRM1—endocrine gland—brain cancer	0.00176	0.0081	CbGeAlD
Naloxone—Nervousness—Procarbazine—brain cancer	0.00176	0.013	CcSEcCtD
Naloxone—OPRM1—head—brain cancer	0.00174	0.008	CbGeAlD
Naloxone—SLCO1A2—midbrain—brain cancer	0.00172	0.00794	CbGeAlD
Naloxone—ESR1—gonad—brain cancer	0.0017	0.00782	CbGeAlD
Naloxone—Tremor—Procarbazine—brain cancer	0.00169	0.0126	CcSEcCtD
Naloxone—SLCO1A2—spinal cord—brain cancer	0.00168	0.00774	CbGeAlD
Naloxone—ESR1—pituitary gland—brain cancer	0.00166	0.00763	CbGeAlD
Naloxone—ABCB1—blood vessel—brain cancer	0.00166	0.00763	CbGeAlD
Naloxone—Hallucination—Hydroxyurea—brain cancer	0.0016	0.0119	CcSEcCtD
Naloxone—OPRM1—central nervous system—brain cancer	0.00158	0.0073	CbGeAlD
Naloxone—Convulsion—Procarbazine—brain cancer	0.00157	0.0116	CcSEcCtD
Naloxone—Hypertension—Procarbazine—brain cancer	0.00156	0.0116	CcSEcCtD
Naloxone—SLCO1A2—endocrine gland—brain cancer	0.00151	0.00697	CbGeAlD
Naloxone—SLCO1A2—head—brain cancer	0.00149	0.00688	CbGeAlD
Naloxone—Vomiting—Lomustine—brain cancer	0.00148	0.011	CcSEcCtD
Naloxone—Angiopathy—Hydroxyurea—brain cancer	0.00146	0.0108	CcSEcCtD
Naloxone—Depression—Carmustine—brain cancer	0.00144	0.0107	CcSEcCtD
Naloxone—Chills—Hydroxyurea—brain cancer	0.00144	0.0107	CcSEcCtD
Naloxone—Tachycardia—Procarbazine—brain cancer	0.00144	0.0107	CcSEcCtD
Naloxone—Hyperhidrosis—Procarbazine—brain cancer	0.00143	0.0106	CcSEcCtD
Naloxone—Depression—Temozolomide—brain cancer	0.00139	0.0103	CcSEcCtD
Naloxone—Cardiac arrest—Etoposide—brain cancer	0.00138	0.0102	CcSEcCtD
Naloxone—Nausea—Lomustine—brain cancer	0.00138	0.0102	CcSEcCtD
Naloxone—CYP2C8—pituitary gland—brain cancer	0.00136	0.00629	CbGeAlD
Naloxone—SLCO1A2—central nervous system—brain cancer	0.00136	0.00628	CbGeAlD
Naloxone—SLCO1A2—cerebellum—brain cancer	0.00133	0.00614	CbGeAlD
Naloxone—Paraesthesia—Procarbazine—brain cancer	0.00132	0.00983	CcSEcCtD
Naloxone—Hallucination—Carmustine—brain cancer	0.00129	0.00959	CcSEcCtD
Naloxone—ESR1—endocrine gland—brain cancer	0.00128	0.00591	CbGeAlD
Naloxone—ESR1—head—brain cancer	0.00127	0.00584	CbGeAlD
Naloxone—Pain—Procarbazine—brain cancer	0.00126	0.00936	CcSEcCtD
Naloxone—OPRM1—brain—brain cancer	0.00126	0.00579	CbGeAlD
Naloxone—Hallucination—Temozolomide—brain cancer	0.00125	0.00927	CcSEcCtD
Naloxone—Convulsion—Hydroxyurea—brain cancer	0.00121	0.00899	CcSEcCtD
Naloxone—Flushing—Carmustine—brain cancer	0.00121	0.00894	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00118	0.00877	CcSEcCtD
Naloxone—Body temperature increased—Procarbazine—brain cancer	0.00117	0.00865	CcSEcCtD
Naloxone—Abdominal pain—Procarbazine—brain cancer	0.00117	0.00865	CcSEcCtD
Naloxone—Cardiac disorder—Temozolomide—brain cancer	0.00116	0.00864	CcSEcCtD
Naloxone—Flushing—Temozolomide—brain cancer	0.00116	0.00864	CcSEcCtD
Naloxone—ESR1—central nervous system—brain cancer	0.00116	0.00533	CbGeAlD
Naloxone—Angiopathy—Temozolomide—brain cancer	0.00114	0.00845	CcSEcCtD
Naloxone—Mental disorder—Carmustine—brain cancer	0.00114	0.00844	CcSEcCtD
Naloxone—Mediastinal disorder—Temozolomide—brain cancer	0.00113	0.00839	CcSEcCtD
Naloxone—ESR1—cerebellum—brain cancer	0.00113	0.00521	CbGeAlD
Naloxone—Chills—Temozolomide—brain cancer	0.00113	0.00836	CcSEcCtD
Naloxone—Nervous system disorder—Hydroxyurea—brain cancer	0.00112	0.0083	CcSEcCtD
Naloxone—Skin disorder—Hydroxyurea—brain cancer	0.00111	0.00823	CcSEcCtD
Naloxone—Mental disorder—Temozolomide—brain cancer	0.0011	0.00816	CcSEcCtD
Naloxone—SLCO1A2—brain—brain cancer	0.00108	0.00499	CbGeAlD
Naloxone—ALB—brain—brain cancer	0.00108	0.00496	CbGeAlD
Naloxone—Tremor—Carmustine—brain cancer	0.00106	0.00786	CcSEcCtD
Naloxone—Asthenia—Procarbazine—brain cancer	0.00106	0.00785	CcSEcCtD
Naloxone—CYP2C8—endocrine gland—brain cancer	0.00106	0.00487	CbGeAlD
Naloxone—Agitation—Carmustine—brain cancer	0.00104	0.00771	CcSEcCtD
Naloxone—Tremor—Temozolomide—brain cancer	0.00102	0.00759	CcSEcCtD
Naloxone—Dyspnoea—Hydroxyurea—brain cancer	0.00102	0.00755	CcSEcCtD
Naloxone—Diarrhoea—Procarbazine—brain cancer	0.00101	0.00749	CcSEcCtD
Naloxone—Agitation—Temozolomide—brain cancer	0.001	0.00745	CcSEcCtD
Naloxone—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000985	0.00731	CcSEcCtD
Naloxone—Convulsion—Carmustine—brain cancer	0.00098	0.00727	CcSEcCtD
Naloxone—Hypertension—Carmustine—brain cancer	0.000976	0.00724	CcSEcCtD
Naloxone—Pain—Hydroxyurea—brain cancer	0.000976	0.00724	CcSEcCtD
Naloxone—Convulsion—Temozolomide—brain cancer	0.000947	0.00702	CcSEcCtD
Naloxone—Hypertension—Temozolomide—brain cancer	0.000943	0.007	CcSEcCtD
Naloxone—Vomiting—Procarbazine—brain cancer	0.000938	0.00696	CcSEcCtD
Naloxone—Flushing—Etoposide—brain cancer	0.000932	0.00692	CcSEcCtD
Naloxone—Cardiac disorder—Etoposide—brain cancer	0.000932	0.00692	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000924	0.00685	CcSEcCtD
Naloxone—ESR1—brain—brain cancer	0.000918	0.00423	CbGeAlD
Naloxone—Angiopathy—Etoposide—brain cancer	0.000911	0.00676	CcSEcCtD
Naloxone—Mediastinal disorder—Etoposide—brain cancer	0.000905	0.00672	CcSEcCtD
Naloxone—Body temperature increased—Hydroxyurea—brain cancer	0.000902	0.00669	CcSEcCtD
Naloxone—Chills—Etoposide—brain cancer	0.000901	0.00669	CcSEcCtD
Naloxone—Tachycardia—Carmustine—brain cancer	0.000901	0.00668	CcSEcCtD
Naloxone—Nausea—Procarbazine—brain cancer	0.000876	0.0065	CcSEcCtD
Naloxone—Nervous system disorder—Temozolomide—brain cancer	0.000874	0.00649	CcSEcCtD
Naloxone—Skin disorder—Temozolomide—brain cancer	0.000866	0.00643	CcSEcCtD
Naloxone—Hyperhidrosis—Temozolomide—brain cancer	0.000862	0.0064	CcSEcCtD
Naloxone—Paraesthesia—Carmustine—brain cancer	0.000829	0.00615	CcSEcCtD
Naloxone—Dyspnoea—Carmustine—brain cancer	0.000823	0.0061	CcSEcCtD
Naloxone—Asthenia—Hydroxyurea—brain cancer	0.000819	0.00608	CcSEcCtD
Naloxone—ABCB1—telencephalon—brain cancer	0.000804	0.0037	CbGeAlD
Naloxone—Paraesthesia—Temozolomide—brain cancer	0.000801	0.00594	CcSEcCtD
Naloxone—Gastrointestinal disorder—Carmustine—brain cancer	0.000797	0.00591	CcSEcCtD
Naloxone—Dyspnoea—Temozolomide—brain cancer	0.000795	0.0059	CcSEcCtD
Naloxone—Pain—Carmustine—brain cancer	0.000789	0.00585	CcSEcCtD
Naloxone—Diarrhoea—Hydroxyurea—brain cancer	0.000781	0.00579	CcSEcCtD
Naloxone—Gastrointestinal disorder—Temozolomide—brain cancer	0.00077	0.00571	CcSEcCtD
Naloxone—Pain—Temozolomide—brain cancer	0.000762	0.00566	CcSEcCtD
Naloxone—Convulsion—Etoposide—brain cancer	0.000757	0.00562	CcSEcCtD
Naloxone—CYP2C8—brain—brain cancer	0.000756	0.00349	CbGeAlD
Naloxone—Hypertension—Etoposide—brain cancer	0.000755	0.0056	CcSEcCtD
Naloxone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000739	0.00548	CcSEcCtD
Naloxone—Body temperature increased—Carmustine—brain cancer	0.000729	0.00541	CcSEcCtD
Naloxone—Abdominal pain—Carmustine—brain cancer	0.000729	0.00541	CcSEcCtD
Naloxone—Vomiting—Hydroxyurea—brain cancer	0.000726	0.00538	CcSEcCtD
Naloxone—CYP3A4—endocrine gland—brain cancer	0.000716	0.0033	CbGeAlD
Naloxone—Body temperature increased—Temozolomide—brain cancer	0.000705	0.00523	CcSEcCtD
Naloxone—Abdominal pain—Temozolomide—brain cancer	0.000705	0.00523	CcSEcCtD
Naloxone—Tachycardia—Etoposide—brain cancer	0.000696	0.00517	CcSEcCtD
Naloxone—Skin disorder—Etoposide—brain cancer	0.000693	0.00514	CcSEcCtD
Naloxone—Hyperhidrosis—Etoposide—brain cancer	0.00069	0.00512	CcSEcCtD
Naloxone—Nausea—Hydroxyurea—brain cancer	0.000678	0.00503	CcSEcCtD
Naloxone—ABCB1—gonad—brain cancer	0.000671	0.00309	CbGeAlD
Naloxone—Asthenia—Carmustine—brain cancer	0.000662	0.00491	CcSEcCtD
Naloxone—ABCB1—pituitary gland—brain cancer	0.000654	0.00302	CbGeAlD
Naloxone—CYP3A4—central nervous system—brain cancer	0.000645	0.00297	CbGeAlD
Naloxone—Paraesthesia—Etoposide—brain cancer	0.000641	0.00475	CcSEcCtD
Naloxone—Asthenia—Temozolomide—brain cancer	0.00064	0.00475	CcSEcCtD
Naloxone—Dyspnoea—Etoposide—brain cancer	0.000636	0.00472	CcSEcCtD
Naloxone—ABCB1—medulla oblongata—brain cancer	0.000631	0.00291	CbGeAlD
Naloxone—Diarrhoea—Carmustine—brain cancer	0.000631	0.00468	CcSEcCtD
Naloxone—Gastrointestinal disorder—Etoposide—brain cancer	0.000616	0.00457	CcSEcCtD
Naloxone—Pain—Etoposide—brain cancer	0.00061	0.00453	CcSEcCtD
Naloxone—Diarrhoea—Temozolomide—brain cancer	0.00061	0.00453	CcSEcCtD
Naloxone—Vomiting—Carmustine—brain cancer	0.000587	0.00435	CcSEcCtD
Naloxone—ABCB1—midbrain—brain cancer	0.000577	0.00266	CbGeAlD
Naloxone—Vomiting—Temozolomide—brain cancer	0.000567	0.00421	CcSEcCtD
Naloxone—Abdominal pain—Etoposide—brain cancer	0.000564	0.00418	CcSEcCtD
Naloxone—Body temperature increased—Etoposide—brain cancer	0.000564	0.00418	CcSEcCtD
Naloxone—ABCB1—spinal cord—brain cancer	0.000563	0.00259	CbGeAlD
Naloxone—Nausea—Carmustine—brain cancer	0.000548	0.00407	CcSEcCtD
Naloxone—Nausea—Temozolomide—brain cancer	0.00053	0.00393	CcSEcCtD
Naloxone—Asthenia—Etoposide—brain cancer	0.000512	0.0038	CcSEcCtD
Naloxone—ABCB1—endocrine gland—brain cancer	0.000507	0.00234	CbGeAlD
Naloxone—ABCB1—head—brain cancer	0.0005	0.00231	CbGeAlD
Naloxone—Diarrhoea—Etoposide—brain cancer	0.000488	0.00362	CcSEcCtD
Naloxone—ABCB1—central nervous system—brain cancer	0.000457	0.0021	CbGeAlD
Naloxone—Vomiting—Etoposide—brain cancer	0.000454	0.00337	CcSEcCtD
Naloxone—ABCB1—cerebellum—brain cancer	0.000446	0.00206	CbGeAlD
Naloxone—Nausea—Etoposide—brain cancer	0.000424	0.00314	CcSEcCtD
Naloxone—ABCB1—brain—brain cancer	0.000363	0.00167	CbGeAlD
Naloxone—TLR4—Immune System—STAT3—brain cancer	0.000119	0.000341	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—HEY1—brain cancer	0.000119	0.00034	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—STRADA—brain cancer	0.000118	0.000339	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—HEY1—brain cancer	0.000118	0.000339	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—PTCH1—brain cancer	0.000117	0.000336	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—SMO—brain cancer	0.000117	0.000336	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—VAV1—brain cancer	0.000117	0.000334	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—DLL1—brain cancer	0.000117	0.000333	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—DLL1—brain cancer	0.000116	0.000332	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—VEGFA—brain cancer	0.000115	0.000328	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000114	0.000328	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—EGFR—brain cancer	0.000114	0.000326	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—SUFU—brain cancer	0.000114	0.000325	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—ABR—brain cancer	0.000111	0.000319	CbGpPWpGaD
Naloxone—ALB—Hemostasis—TRPC6—brain cancer	0.000111	0.000319	CbGpPWpGaD
Naloxone—CREB1—Immune System—VAV1—brain cancer	0.000111	0.000317	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—GFAP—brain cancer	0.00011	0.000313	CbGpPWpGaD
Naloxone—TLR4—Immune System—EGFR—brain cancer	0.000108	0.00031	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—GLI2—brain cancer	0.000108	0.000308	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000108	0.000308	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—RELA—brain cancer	0.000107	0.000305	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—ERBB2—brain cancer	0.000106	0.000304	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—VAV1—brain cancer	0.000106	0.000303	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000105	0.000301	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—TP53—brain cancer	0.000104	0.000299	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—HEY1—brain cancer	0.000104	0.000297	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—EGFR—brain cancer	0.000103	0.000295	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000103	0.000295	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	0.000103	0.000294	CbGpPWpGaD
Naloxone—CREB1—Disease—VAV1—brain cancer	0.000102	0.000292	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—DLL1—brain cancer	0.000102	0.000291	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000101	0.00029	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—GLI1—brain cancer	0.000101	0.00029	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—SHH—brain cancer	9.91e-05	0.000283	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—ABR—brain cancer	9.89e-05	0.000283	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.88e-05	0.000283	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—SHH—brain cancer	9.88e-05	0.000283	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—VAV1—brain cancer	9.86e-05	0.000282	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	9.65e-05	0.000276	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—SUFU—brain cancer	9.6e-05	0.000275	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—ENO2—brain cancer	9.59e-05	0.000274	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TRPC6—brain cancer	9.55e-05	0.000273	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—GLI2—brain cancer	9.55e-05	0.000273	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TRPC6—brain cancer	9.52e-05	0.000272	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—RELA—brain cancer	9.43e-05	0.00027	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—SMO—brain cancer	9.39e-05	0.000269	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—PTCH1—brain cancer	9.39e-05	0.000269	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—ERBB2—brain cancer	9.37e-05	0.000268	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—SMO—brain cancer	9.36e-05	0.000268	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—PTCH1—brain cancer	9.36e-05	0.000268	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—CTNNB1—brain cancer	9.28e-05	0.000266	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—GFAP—brain cancer	9.26e-05	0.000265	CbGpPWpGaD
Naloxone—CREB1—Immune System—PDGFRA—brain cancer	9.07e-05	0.000259	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—RELA—brain cancer	9.06e-05	0.000259	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—ERBB2—brain cancer	9e-05	0.000257	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—GLI1—brain cancer	8.98e-05	0.000257	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—VAV1—brain cancer	8.95e-05	0.000256	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—DNMT1—brain cancer	8.9e-05	0.000254	CbGpPWpGaD
Naloxone—CREB1—Disease—HES1—brain cancer	8.79e-05	0.000251	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—HEY1—brain cancer	8.78e-05	0.000251	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—SHH—brain cancer	8.66e-05	0.000248	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	8.65e-05	0.000247	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—DLL1—brain cancer	8.61e-05	0.000246	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—SUFU—brain cancer	8.51e-05	0.000243	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	8.45e-05	0.000242	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—PIK3CG—brain cancer	8.45e-05	0.000242	CbGpPWpGaD
Naloxone—CREB1—Disease—PDGFRA—brain cancer	8.37e-05	0.000239	CbGpPWpGaD
Naloxone—ALB—Hemostasis—VAV1—brain cancer	8.35e-05	0.000239	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TRPC6—brain cancer	8.35e-05	0.000239	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—GFAP—brain cancer	8.21e-05	0.000235	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—SMO—brain cancer	8.21e-05	0.000235	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PTCH1—brain cancer	8.21e-05	0.000235	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—CTNNB1—brain cancer	8.2e-05	0.000235	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—VEGFA—brain cancer	8.17e-05	0.000234	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—CYP2C9—brain cancer	8.15e-05	0.000233	CbGpPWpGaD
Naloxone—ALB—Metabolism—CYP2C9—brain cancer	8.11e-05	0.000232	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—STAT3—brain cancer	8.09e-05	0.000232	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—ESR2—brain cancer	7.99e-05	0.000228	CbGpPWpGaD
Naloxone—CREB1—Immune System—IRS2—brain cancer	7.96e-05	0.000228	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	7.86e-05	0.000225	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—HEY1—brain cancer	7.78e-05	0.000223	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—PIK3CG—brain cancer	7.69e-05	0.00022	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—PIK3CG—brain cancer	7.67e-05	0.000219	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—DLL1—brain cancer	7.63e-05	0.000218	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—NOTCH2—brain cancer	7.56e-05	0.000216	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—NOTCH2—brain cancer	7.51e-05	0.000215	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—NOTCH2—brain cancer	7.48e-05	0.000214	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—PIK3CG—brain cancer	7.41e-05	0.000212	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—EGFR—brain cancer	7.36e-05	0.00021	CbGpPWpGaD
Naloxone—CREB1—Disease—IRS2—brain cancer	7.35e-05	0.00021	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—SHH—brain cancer	7.32e-05	0.000209	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	7.24e-05	0.000207	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—VAV1—brain cancer	7.16e-05	0.000205	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—VAV1—brain cancer	7.14e-05	0.000204	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—CYP2C9—brain cancer	7.1e-05	0.000203	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TRPC6—brain cancer	7.06e-05	0.000202	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	6.95e-05	0.000199	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—SMO—brain cancer	6.94e-05	0.000198	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PTCH1—brain cancer	6.94e-05	0.000198	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—BSG—brain cancer	6.93e-05	0.000198	CbGpPWpGaD
Naloxone—ALB—Metabolism—BSG—brain cancer	6.89e-05	0.000197	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	6.88e-05	0.000197	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—PIK3CG—brain cancer	6.72e-05	0.000192	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—NOTCH2—brain cancer	6.56e-05	0.000188	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—EGFR—brain cancer	6.5e-05	0.000186	CbGpPWpGaD
Naloxone—CREB1—Disease—APC—brain cancer	6.49e-05	0.000186	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—SHH—brain cancer	6.49e-05	0.000186	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—SIRT1—brain cancer	6.43e-05	0.000184	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—PIK3CG—brain cancer	6.26e-05	0.000179	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TRPC6—brain cancer	6.26e-05	0.000179	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—VAV1—brain cancer	6.26e-05	0.000179	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—EGFR—brain cancer	6.24e-05	0.000178	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—HES1—brain cancer	6.16e-05	0.000176	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	6.15e-05	0.000176	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PTCH1—brain cancer	6.15e-05	0.000176	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—SMO—brain cancer	6.15e-05	0.000176	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—HES1—brain cancer	6.14e-05	0.000176	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	6.06e-05	0.000173	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—BSG—brain cancer	6.04e-05	0.000173	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—IDH1—brain cancer	5.96e-05	0.000171	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—IL2—brain cancer	5.94e-05	0.00017	CbGpPWpGaD
Naloxone—ALB—Metabolism—IDH1—brain cancer	5.93e-05	0.00017	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—PDGFRA—brain cancer	5.86e-05	0.000168	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—PDGFRA—brain cancer	5.84e-05	0.000167	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—SPP1—brain cancer	5.69e-05	0.000163	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—PIK3CG—brain cancer	5.68e-05	0.000163	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—SPP1—brain cancer	5.67e-05	0.000162	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	5.57e-05	0.000159	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—NOTCH2—brain cancer	5.55e-05	0.000159	CbGpPWpGaD
Naloxone—CREB1—Immune System—RELA—brain cancer	5.49e-05	0.000157	CbGpPWpGaD
Naloxone—CREB1—Immune System—ERBB2—brain cancer	5.46e-05	0.000156	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	5.45e-05	0.000156	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—IL2—brain cancer	5.41e-05	0.000155	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—IL2—brain cancer	5.4e-05	0.000154	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—HES1—brain cancer	5.38e-05	0.000154	CbGpPWpGaD
Naloxone—ALB—Hemostasis—PIK3CG—brain cancer	5.3e-05	0.000152	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—VAV1—brain cancer	5.29e-05	0.000151	CbGpPWpGaD
Naloxone—ESR1—Generic Transcription Pathway—MYC—brain cancer	5.23e-05	0.00015	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—IL2—brain cancer	5.21e-05	0.000149	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—IDH1—brain cancer	5.19e-05	0.000149	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—IRS2—brain cancer	5.15e-05	0.000147	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—IRS2—brain cancer	5.13e-05	0.000147	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PDGFRA—brain cancer	5.12e-05	0.000147	CbGpPWpGaD
Naloxone—CREB1—Disease—ERBB2—brain cancer	5.04e-05	0.000144	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—SPP1—brain cancer	4.97e-05	0.000142	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL2—brain cancer	4.95e-05	0.000142	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—NOTCH2—brain cancer	4.92e-05	0.000141	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.86e-05	0.000139	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.83e-05	0.000138	CbGpPWpGaD
Naloxone—CREB1—Immune System—CTNNB1—brain cancer	4.78e-05	0.000137	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—IL2—brain cancer	4.73e-05	0.000135	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ENO2—brain cancer	4.71e-05	0.000135	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—VAV1—brain cancer	4.69e-05	0.000134	CbGpPWpGaD
Naloxone—ALB—Metabolism—ENO2—brain cancer	4.69e-05	0.000134	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	4.58e-05	0.000131	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—HES1—brain cancer	4.55e-05	0.00013	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—APC—brain cancer	4.55e-05	0.00013	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—PIK3CG—brain cancer	4.55e-05	0.00013	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—PIK3CG—brain cancer	4.53e-05	0.00013	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—APC—brain cancer	4.53e-05	0.00013	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—IRS2—brain cancer	4.5e-05	0.000129	CbGpPWpGaD
Naloxone—CREB1—Disease—CTNNB1—brain cancer	4.41e-05	0.000126	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—IL2—brain cancer	4.4e-05	0.000126	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—PIK3CG—brain cancer	4.4e-05	0.000126	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—CYP2C9—brain cancer	4.38e-05	0.000125	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PDGFRA—brain cancer	4.33e-05	0.000124	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—SPP1—brain cancer	4.2e-05	0.00012	CbGpPWpGaD
Naloxone—CREB1—Immune System—STAT3—brain cancer	4.16e-05	0.000119	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—EGFR—brain cancer	4.14e-05	0.000118	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—EGFR—brain cancer	4.13e-05	0.000118	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ENO2—brain cancer	4.11e-05	0.000117	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—HES1—brain cancer	4.03e-05	0.000115	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—IL2—brain cancer	4e-05	0.000114	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—APC—brain cancer	3.97e-05	0.000114	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PIK3CG—brain cancer	3.97e-05	0.000114	CbGpPWpGaD
Naloxone—CREB1—Disease—STAT3—brain cancer	3.84e-05	0.00011	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PDGFRA—brain cancer	3.84e-05	0.00011	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—IRS2—brain cancer	3.8e-05	0.000109	CbGpPWpGaD
Naloxone—CREB1—Immune System—EGFR—brain cancer	3.78e-05	0.000108	CbGpPWpGaD
Naloxone—ALB—Hemostasis—IL2—brain cancer	3.73e-05	0.000107	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—SPP1—brain cancer	3.73e-05	0.000107	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—BSG—brain cancer	3.72e-05	0.000106	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—EGFR—brain cancer	3.62e-05	0.000104	CbGpPWpGaD
Naloxone—CREB1—Disease—MYC—brain cancer	3.57e-05	0.000102	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—RELA—brain cancer	3.55e-05	0.000102	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—RELA—brain cancer	3.54e-05	0.000101	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—ERBB2—brain cancer	3.53e-05	0.000101	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—ERBB2—brain cancer	3.52e-05	0.000101	CbGpPWpGaD
Naloxone—CREB1—Disease—EGFR—brain cancer	3.49e-05	9.99e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IRS2—brain cancer	3.37e-05	9.64e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PIK3CG—brain cancer	3.36e-05	9.6e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—APC—brain cancer	3.36e-05	9.6e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—IDH1—brain cancer	3.2e-05	9.16e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—IL2—brain cancer	3.2e-05	9.15e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—IL2—brain cancer	3.19e-05	9.12e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—VEGFA—brain cancer	3.17e-05	9.07e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CCND1—brain cancer	3.12e-05	8.92e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CCND1—brain cancer	3.11e-05	8.89e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—RELA—brain cancer	3.1e-05	8.88e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CTNNB1—brain cancer	3.09e-05	8.83e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—ERBB2—brain cancer	3.08e-05	8.82e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CTNNB1—brain cancer	3.08e-05	8.8e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—EGFR—brain cancer	3.06e-05	8.75e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—APC—brain cancer	2.98e-05	8.52e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PIK3CG—brain cancer	2.98e-05	8.52e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—IL2—brain cancer	2.8e-05	8e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CCND1—brain cancer	2.73e-05	7.8e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—VEGFA—brain cancer	2.72e-05	7.78e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—VEGFA—brain cancer	2.71e-05	7.75e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CTNNB1—brain cancer	2.7e-05	7.72e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—STAT3—brain cancer	2.69e-05	7.7e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—STAT3—brain cancer	2.68e-05	7.67e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—RELA—brain cancer	2.62e-05	7.5e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—ERBB2—brain cancer	2.61e-05	7.46e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ENO2—brain cancer	2.53e-05	7.24e-05	CbGpPWpGaD
Naloxone—ESR1—Gene Expression—MYC—brain cancer	2.52e-05	7.21e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MYC—brain cancer	2.5e-05	7.15e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MYC—brain cancer	2.49e-05	7.13e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—EGFR—brain cancer	2.45e-05	7e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—EGFR—brain cancer	2.44e-05	6.98e-05	CbGpPWpGaD
Naloxone—ALB—Hemostasis—TP53—brain cancer	2.4e-05	6.85e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—VEGFA—brain cancer	2.38e-05	6.8e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—IL2—brain cancer	2.36e-05	6.76e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—STAT3—brain cancer	2.35e-05	6.73e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—RELA—brain cancer	2.33e-05	6.65e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—ERBB2—brain cancer	2.31e-05	6.61e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CCND1—brain cancer	2.3e-05	6.59e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CTNNB1—brain cancer	2.28e-05	6.52e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MYC—brain cancer	2.19e-05	6.25e-05	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PIK3CG—brain cancer	2.16e-05	6.19e-05	CbGpPWpGaD
Naloxone—ALB—Metabolism—PIK3CG—brain cancer	2.15e-05	6.15e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—EGFR—brain cancer	2.14e-05	6.12e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—IL2—brain cancer	2.09e-05	5.99e-05	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—TP53—brain cancer	2.05e-05	5.88e-05	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—TP53—brain cancer	2.05e-05	5.86e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CCND1—brain cancer	2.04e-05	5.84e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CTNNB1—brain cancer	2.02e-05	5.79e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—VEGFA—brain cancer	2.01e-05	5.74e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—STAT3—brain cancer	1.99e-05	5.69e-05	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PIK3CG—brain cancer	1.88e-05	5.39e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MYC—brain cancer	1.85e-05	5.29e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—EGFR—brain cancer	1.81e-05	5.17e-05	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—TP53—brain cancer	1.8e-05	5.14e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—VEGFA—brain cancer	1.78e-05	5.09e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—STAT3—brain cancer	1.76e-05	5.04e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MYC—brain cancer	1.64e-05	4.69e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—EGFR—brain cancer	1.6e-05	4.58e-05	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—TP53—brain cancer	1.52e-05	4.34e-05	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—TP53—brain cancer	1.35e-05	3.85e-05	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PIK3CG—brain cancer	1.16e-05	3.32e-05	CbGpPWpGaD
